A practical workflow for isolation and low-input multi-omic and functional profiling of neutrophils from tumor tissue

Tumor-associated neutrophils (TAN) are increasingly recognized as major regulators of tumor progression, metastasis, immune suppression, and response to immunotherapy. However, mechanistic studies of TAN remain technically challenging due to the frequently limited numbers recoverable from individual tumor specimens, susceptibility to activation during tissue processing, rapid apoptosis ex vivo , and poor survival following fluorescence-activated cell sorting (FACS). These limitations often compromise downstream molecular and functional analyses and contribute to substantial variability between laboratories. Importantly, the difficulty of recovering highly viable TAN has also limited direct functional validation of neutrophil states identified by transcriptomic profiling, leading many studies to infer functional heterogeneity primarily from transcriptional signatures. Here, we describe a practical workflow for the isolation of highly viable TAN from murine and human solid tumors. The protocol combines gentle tissue dissociation, sterile low-stress cell sorting conditions, post-sort handling, and downstream applications including single-cell RNA sequencing (scRNA-seq) with bioinformatic considerations, bulk RNA sequencing, CUT&RUN epigenomic profiling, mini suppression assays, ex vivo cultures, real time quantitative PCR and western blotting. Particular emphasis is placed on pre-analytical variables that critically affect TAN viability and on neutrophil-specific considerations for scRNA-seq quality control and interpretation. The workflow is designed to be adaptable to different tumor types and enables robust characterization of low-frequency neutrophil populations that are typically difficult to study using conventional approaches, facilitating experimental validation of the biological functions associated with transcriptionally defined TAN states.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-04
DOI
https://doi.org/10.3389/fimmu.2026.1989114
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A practical workflow for isolation and low-input multi-omic and functional profiling of neutrophils from tumor tissue

Filippo Veglia, Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu
Frontiers in Immunology
Immune cells in cancer
article

A practical workflow for isolation and low-input multi-omic and functional profiling of neutrophils from tumor tissue

Filippo Veglia, Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu
article en

Abstract

Tumor-associated neutrophils (TAN) are increasingly recognized as major regulators of tumor progression, metastasis, immune suppression, and response to immunotherapy. However, mechanistic studies of TAN remain technically challenging due to the frequently limited numbers recoverable from individual tumor specimens, susceptibility to activation during tissue processing, rapid apoptosis ex vivo , and poor survival following fluorescence-activated cell sorting (FACS). These limitations often compromise downstream molecular and functional analyses and contribute to substantial variability between laboratories. Importantly, the difficulty of recovering highly viable TAN has also limited direct functional validation of neutrophil states identified by transcriptomic profiling, leading many studies to infer functional heterogeneity primarily from transcriptional signatures. Here, we describe a practical workflow for the isolation of highly viable TAN from murine and human solid tumors. The protocol combines gentle tissue dissociation, sterile low-stress cell sorting conditions, post-sort handling, and downstream applications including single-cell RNA sequencing (scRNA-seq) with bioinformatic considerations, bulk RNA sequencing, CUT&RUN epigenomic profiling, mini suppression assays, ex vivo cultures, real time quantitative PCR and western blotting. Particular emphasis is placed on pre-analytical variables that critically affect TAN viability and on neutrophil-specific considerations for scRNA-seq quality control and interpretation. The workflow is designed to be adaptable to different tumor types and enables robust characterization of low-frequency neutrophil populations that are typically difficult to study using conventional approaches, facilitating experimental validation of the biological functions associated with transcriptionally defined TAN states.

Frontiers in ImmunologyVol. 17
The Wistar Institute (US), Moffitt Cancer Center (US)
Openalex Percentile: Top 20%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon